{"name":"EpiCept Corporation","slug":"epicept-corporation","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Pain","slug":"pain","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"EpiCept-NP-1 Cream","genericName":"EpiCept-NP-1 Cream","slug":"epicept-np-1-cream","indication":"Moderate to severe pain in patients with postherpetic neuralgia","status":"phase_2"}]},{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Gabapentin Capsules","genericName":"Gabapentin Capsules","slug":"gabapentin-capsules","indication":"Postherpetic neuralgia","status":"marketed"}]}],"pipeline":[{"name":"EpiCept-NP-1 Cream","genericName":"EpiCept-NP-1 Cream","slug":"epicept-np-1-cream","phase":"phase_2","mechanism":"EpiCept-NP-1 Cream is a topical analgesic that works by blocking the production of substance P, a neuropeptide involved in pain transmission.","indications":["Moderate to severe pain in patients with postherpetic neuralgia"],"catalyst":""},{"name":"Gabapentin Capsules","genericName":"Gabapentin Capsules","slug":"gabapentin-capsules","phase":"marketed","mechanism":"Gabapentin reduces neuronal excitability by binding to the alpha-2-delta subunit of voltage-gated calcium channels, thereby decreasing the release of excitatory neurotransmitters.","indications":["Postherpetic neuralgia","Partial-onset seizures (adjunctive therapy)","Neuropathic pain"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxNN0tMQWZTNk5mTERnaDR5NFNVcmhVaUk2dEhmTm9VRXlwNWluR0JnbG8zc0xDYTlzVVpGWnNzMG1Ba09yOVdDUlhPN0F1UGFDVGFUd1Q3MGhBVXJqMHEwSW02MU1ya0tPRlUwbXdEbnJVUVY5QmhJWUtsQ3dnVFpKb0MwbUprZGZLZFBwdk11dEJqT2NvQ2NYbWswZFBBaXPSAacBQVVfeXFMUHJIMldGT2pmQTZSazluN3YtVG9jN3RLbFdJcWpnTk03T1ZlcGp0ODB1U2Y1VlktWUpiZURpSmVncWZzQ1hkVk5jX1p1dXJtUklsUUozUU0tNEpQdDFoUmN2TWIwTkQ0aURiZ2d6X3ZqeHZuTFlOdFU1WlVBN0tlSzVHTHZURkJjbzd4VUpLYnI0dnR4WlpKS3lLaGtSNnotWGpWM293NGM?oc=5","date":"2014-02-21","type":"pipeline","source":"Westchester Magazine","summary":"Biotech Guide: A List of Westchester’s Biotech Companies - Westchester Magazine","headline":"Biotech Guide: A List of Westchester’s Biotech Companies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxNNG9Jdnp0WHNFVVhvMmNaaks3bFFLZElzZ1JoWEo5bXFVeVFFNzdZcWFSZXprcENtb2VSdGtEZHZ5azg4d0NpTnduMnc1dU84c0tmbXk4amxZSmxuTTRyVnVpWm1lN1JyOThHcXpDMUtxRHhEUDFpcGoyWmVaU29yRTExQWJjYTN3WkJGWE84S2FRamFHZEE?oc=5","date":"2012-09-24","type":"pipeline","source":"AOL.com","summary":"EpiCept Corporation Raises $0.8 Million from Immediate Exercise of Re-priced Warrants - AOL.com","headline":"EpiCept Corporation Raises $0.8 Million from Immediate Exercise of Re-priced Warrants","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxNM2ZsaG1IazEzdzkxZm1BUVVnNHdwaEdqWExOTXI2Rll0WF9fZFZHTUVSeDhYY0pQVnlYdkdoNWhiT29FZzNzZWhxb2UtTjdwd21FWkllQjFITl93MWVEcG40WnBJdFZJQ3pQcnkwQmp4bVRHZUROLURvZFVEM1EyS2hmTExwUXdPRmVGU2E1OFNKYXJ5V2FwQjZ5aUFPQWppX3c?oc=5","date":"2010-08-23","type":"regulatory","source":"Genetic Engineering and Biotechnology News","summary":"EpiCept’s Stock Slumps as FDA Asks for More Clinical Data on Ceplene - Genetic Engineering and Biotechnology News","headline":"EpiCept’s Stock Slumps as FDA Asks for More Clinical Data on Ceplene","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_2":1,"marketed":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}